November 12, 2010 – A noninvasive imaging technique may help effectively diagnose prostate cancer at an early stage without ionizing radiation. According to a report at the Advances in Contrast Ultrasound – ICUS Bubble Conference, contrast-enhanced ultrasound (CEUS) could help diagnose the most common cancer afflicting American men. "CEUS represents an important opportunity for early detection and for guiding local therapy," said Massimo Mischi of Eindhoven University of Technology in the Netherlands. His work was funded by the Dutch government. Men with elevated levels of prostate specific antigen (PSA) are considered at risk of having prostate cancer, and are typically referred for diagnostic biopsies. But PSA levels may be elevated in many men who do not have prostate cancer and most biopsies are unnecessary, Mischi said. "We know that as many as 76 percent of biopsies were in retrospect unnecessary," he said. "Effective diagnostic imaging is essential because localized therapies can be effective." In CEUS imaging, patients are injected with a special contrast agent that does not contain dye and does not require ionizing radiation. It is approved by the U.S. Food and Drug Administration (FDA) for certain types of cardiac imaging and is approved in Europe, Canada, Asia and South America for pinpointing disease and tumors in other parts of the body. "CEUS can offer a safe and cost effective means of improving the accuracy of ultrasound diagnoses," said Steven Feinstein, M.D., director of echocardiography at Rush University Medical Center in Chicago, director of the conference and co-president of the International Contrast Ultrasound Society. For more information: www.icus-society.org
News | November 12, 2010
New Study Shows Promise for Detecting Prostate Cancer
News | Women's Health | August 20, 2019
A small but concerning number of women are exposed to a commonly used magnetic resonance imaging (MRI) contrast agent...
News | Image Guided Radiation Therapy (IGRT) | August 19, 2019
August 19, 2019 — ViewRay Inc.
News | Neuro Imaging | August 16, 2019
A drug used to treat attention-deficit/hyperactivity disorder (ADHD) appears to affect development of the brain’s...
Technology | Interventional Radiology | August 16, 2019
Profound Medical Corp. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to...
News | Radiation Therapy | August 15, 2019
Henry Ford Cancer Institute is first-in-the-world to enroll a glioblastoma patient in the GBM AGILE Trial (Adaptive...
News | Pediatric Imaging | August 14, 2019
August 14, 2019 – Children’s veins
News | Brachytherapy Systems | August 14, 2019
August 14, 2019 — Isoray announced a trio of studies recently reported at scientific meetings and published in medica
News | Mammography | August 14, 2019
Image visualization company Imago Systems announced it has signed a know-how license with Mayo Clinic. The multi-year...
News | Artificial Intelligence | August 13, 2019
University of California Los Angeles (UCLA) researchers have developed an artificial intelligence (AI) system that...
News | Cardiovascular Ultrasound | August 07, 2019
Heart failure is the fourth most common cause for all admission to U.S. hospitals, and it is the most common reason for...